Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCO vs GSK✓SelectedUSD · GSKMCO vs GSK performance historyLatest closeAs of-0.85%11/20
Stock and ETF performance explorer

MCO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-0.6%
GSK return
+6.1%
Excess return
-6.7%
Maximum drawdown
-23.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-0.1%-0.7%-0.8%
7D-7.9%-5.3%-2.6%-7.4%
30D-2.7%-3.7%+0.9%-2.4%
3M-6.2%-7.3%+1.1%-5.9%
6M+5.5%-4.2%+9.8%+6.0%
YTD-7.8%+0.9%-8.7%-7.2%
1Y-0.6%+7.3%-7.8%-0.5%
All-0.6%+6.1%-6.7%-0.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling